Fluorescence-guided surgery with 5-aminolevulinic acid (ALA) for brain tumor

Fluorescence-guided surgery with 5-aminolevulinic acid (ALA) for brain tumor - Fluorescence-guided surgery with 5-aminolevulinic acid (ALA) for brain tumor

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003594

Enrollment

100

Registered

2010-05-15

Start date

2010-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant brain tumor

Interventions

Oral administration of 5-aminolevulinic acid one hour before surgery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Gadolinium enhanced brain tumors on magnetic resonance images

Exclusion criteria

Exclusion criteria: Porphyria Patients who did not agree with this study Patients whom doctors decided as not a candidate

Design outcomes

Primary

Measure	Time frame
Evaluation of the tumor resection rate	—

Countries

Japan

Contacts

Public ContactTeruyoshi Kageji

The University of Tokushima Department of Neurosurgey

088-633-7149

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026